Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study on Chemotherapy Induced Peripheral Neuropathy: Preventive Approach Using Venlafaxine

NCT05875610 is registered in ClinicalTrials.gov with Mit Ghamr Oncology Center as lead sponsor.

NCT NCT05875610
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05875610 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study on Chemotherapy Induced Peripheral Neuropathy: Preventive Approach Using Venlafaxine
Lead sponsor
Mit Ghamr Oncology Center
Phase
Phase 4
Overall status
Unknown status
Start date
May 1, 2023
Completion date
December 1, 2023
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral neuropathy due to chemotherapy